ERBB2 and breast carcinoma: About 15–20% of all breast cancer cases display an amplification and/or overexpression of the ERBB2 gene, which encodes the human epidermal growth factor receptor 2 (HER2), and are referred to as “HER2-positive breast cancer” [2,3].